+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Drugs of Abuse Testing Market Report and Forecast 2023-2031

  • PDF Icon


  • 140 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5805815
The global drugs of abuse testing market value was USD 6.2 billion in 2022, driven by the increasing prevalence drug abuse and the opioid crisis across the globe. The market size is anticipated to grow at a CAGR of 7.1% during the forecast period of 2023-2031 to achieve a value of USD 11.5 billion by 2031.


Drugs of Abuse Testing refers to the detection and analysis of illicit substances or prescription medications in biological samples such as urine, blood, or saliva. It plays a crucial role in various settings, including workplace drug testing, law enforcement, forensic investigations, and clinical toxicology. The objective of drugs of abuse testing is to identify the presence of drugs or their metabolites in the body, indicating recent drug use or potential substance abuse.

Key Trends in the Drugs of Abuse Testing Market

Some key trends involved in the drugs of abuse testing market are as follows:
  • Increasing Substance Abuse Epidemic: The rising prevalence of drug abuse worldwide, including the misuse of opioids, stimulants, cannabis, and other illicit substances, has fueled the demand for drugs of abuse testing. Government initiatives and public awareness campaigns aimed at combating substance abuse are driving the adoption of testing methods
  • Technological Advancements: The field of drugs of abuse testing has witnessed significant advancements in testing methods and technologies. Rapid and point-of-care testing devices, such as immunoassays and oral fluid tests, provide quick and convenient results. Furthermore, the emergence of advanced analytical techniques, including mass spectrometry and chromatography, has improved the accuracy and sensitivity of drug detection
  • Legalization of Cannabis: The growing legalization of cannabis for medical and recreational purposes in several countries has impacted the drugs of abuse testing market. The need for accurate and reliable testing methods to differentiate between therapeutic and illicit cannabis use has increased. This has led to the development of specialized tests capable of detecting specific cannabis compounds and determining impairment levels

Drugs of Abuse Testing Market Segmentations

Market Breakup by Product Type


  • Immunoassay Analyzers
  • Chromatographic Devices
  • Breath Analyzers

Rapid Testing Devices

  • Urine Testing Devices
  • Oral Fluid Testing Devices


  • Others

Market Breakup by Sample Type

  • Saliva
  • Urine
  • Blood
  • Others

Market Breakup by End Users

  • Hospitals
  • Diagnostics Laboratories
  • Forensic Laboratories
  • Others

Market Breakup by Region

North America

  • United States of America
  • Canada


  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Drugs of Abuse Testing Market Scenario

The Drugs of Abuse Testing market is an essential component of the healthcare industry, focusing on the detection and analysis of illicit substances and prescription medications in biological samples. The market plays a vital role in various sectors, including healthcare, law enforcement, workplace safety, and forensic investigations. Drugs of abuse testing is critical in identifying drug use patterns, monitoring substance abuse, and ensuring public safety.

The market for Drugs of Abuse Testing is driven by several factors. Firstly, the rising prevalence of drug abuse and the opioid crisis globally have created a pressing need for effective testing methods. The increased awareness of the social and economic burden associated with substance abuse has led to the implementation of stringent regulations and workplace drug testing programs.

Technological advancements have also played a significant role in shaping the market. Innovations in testing methods, such as rapid immunoassays, oral fluid tests, and advanced analytical techniques like mass spectrometry, have improved the accuracy, sensitivity, and speed of drug detection. These advancements have led to the development of more reliable and convenient testing solutions.

Drugs of Abuse Testing Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Danaher Corporation (Beckman Coulter, Inc.)
  • Quest Diagnostics Inc
  • LabCorp
  • Drägerwerk AG & Co. KGaA
  • Abbot Laboratories
  • Express Diagnostics International INC
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • Siemens AG
  • Thermo fisher Scientific inc.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Drugs of Abuse Testing Market Overview
3.1 Drugs of Abuse Testing Market Historical Value (2016-2022)
3.2 Drugs of Abuse Testing Market Forecast Value (2023-2031)
4 Drugs of Abuse Testing Market Landscape
4.1 Drugs of Abuse Testing: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Drugs of Abuse Testing Product Landscape
4.2.1 Analysis by Device Type
4.2.2 Analysis by Technology
4.2.3 Analysis by End User
5 Drugs of Abuse Testing Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Drugs of Abuse Testing Market Segmentation
6.1 Drugs of Abuse Testing Market by Product Type
6.1.1 Market Overview
6.1.2 Analyzers Market Overview Immunoassay Analyzers Chromatographic Devices Breath Analyzers
6.1.3 Rapid Testing Devices Market Overview Urine Testing Devices Oral Fluid Testing Devices
6.1.4 Consumables
6.1.5 Others
6.2 Drugs of Abuse Testing Market by Sample Type
6.2.1 Market Overview
6.2.2 Saliva
6.2.3 Urine
6.2.4 Blood
6.2.5 Others
6.3 Drugs of Abuse Testing Market by End Users
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Diagnostics Laboratories
6.3.4 Forensic Laboratories
6.3.5 Others
6.4 Drugs of Abuse Testing Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Drugs of Abuse Testing
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Drugs of Abuse Testing
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Drugs of Abuse Testing
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.6 Australia
9.7 Others
10 Latin America Drugs of Abuse Testing
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Drugs of Abuse Testing
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Danaher Corporation (Beckman Coulter, Inc.)
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Quest Diagnostics Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 LabCorp
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Drägerwerk AG & Co. KGaA
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Abbot Laboratories
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Express Diagnostics International INC
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Laboratory Corporation Of America Holdings
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Quest Diagnostics Incorporated
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Siemens AG
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Thermo fisher Scientific inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
18 Drugs of Abuse Testing - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Danaher Corporation (Beckman Coulter Inc.)
  • Quest Diagnostics Inc.
  • LabCorp
  • Drägerwerk AG & Co. KGaA
  • Abbot Laboratories
  • Express Diagnostics International INC
  • Laboratory Corporation Of America Holdings
  • Quest Diagnostics Incorporated
  • Siemens AG
  • Thermo fisher Scientific inc.



Table Information